Drug-Resistant Tuberculosis

Tuberculosis: Trial of multidrug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior

by

LONDON – A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and more patient data was extremely unlikely to change the trial’s outcome. TB-PRACTECAL, a phase II/III clinical … Read more

endTB trial: First patient enrolls for clinical trials of novel, short and all-oral regimens for multidrug-resistant tuberculosis in India

by

Pune, India: Doctors Without Borders/ Médecins Sans Frontières (MSF) in collaboration with Indian Council for Medical Research (ICMR)- National AIDS Research Institute (NARI) and Department of Health Service, Government of Maharashtra is initiating two major clinical trials that aim at generating clinical evidence on the safety and efficacy of novel, short and all-oral regimens for the most difficult-to-treat … Read more

Tuberculosis: MSF welcomes WHO revision in TB guidelines and urges greater access and affordability in India to new regimen

by

New Delhi, India: Doctors Without Borders/Medecins Sans Frontieres (MSF) has welcomed the revision made by the World Health Organisation (WHO) to its tuberculosis (TB) guidelines, allowing for safe use of a treatment regimen including both bedaquiline and delamanid for drug-resistant tuberculosis (DR-TB) patients, while urging a faster uptake in India for patients with extensively drug-resistant … Read more

5 barriers from Big Pharma preventing people getting lifesaving TB drugs

by

Tuberculosis (TB) is not a disease of the past. Every year, 1.5 million people die of it – that’s more than 4,000 people every day. But pharma companies are not providing the SOLUTION as you might expect.  Here we list 5 BARRIERS which pharma corporation Johnson and Johnson (J&J) and other Big Pharma are creating that … Read more

World Tuberculosis Day: “It’s time” to end the suffering and accelerate access to all oral regimen

by

Mumbai (India) – As of February 2020, the MSF private clinic in Govandi, Mumbai has initiated 188 drug-resistant tuberculosis (DR-TB) patients on treatment regimen which includes Bedaquiline and Delamanid.  Globally, an estimated 10 million people fell ill with tuberculosis (TB) in 2018 with India bearing the largest share of global TB burden (27%) much more than … Read more

Manipur: Working with HIV and TB patients in remote areas

by

By Edoardo Nicolotti, Project Coordinator, Manipur After working in Nepal for several years when I got the opportunity to work in Manipur, I was really excited. In my mind, I had the impression that Manipur would be very similar to Nepal but six months into the project, I realized I couldn’t be more wrong. Culturally … Read more

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people

by

Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt the opening ceremony of the 50th Union World Conference on Lung Health in Hyderabad today, … Read more

Chhattisgarh: Treating tuberculosis in the jungle

by

Since 2006, MSF is working in Sukma district of Southern Chhattisgarh in India, place of a longstanding low-intensity conflict between Indian security forces and Left-Wing Extremist group. The MSF team works to provide primary health care services to the population affected by the conflict. treating tb in the jungle by MSF on Exposure

Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug

by

GENEVA – Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who need it, in order to allow scale-up of drug-resistant tuberculosis (DR-TB) treatment and reduce deaths.   … Read more

Manipur: Providing patient-centered HIV, TB, and hepatitis care to patients

by

When Thongsei Lupho, 44, first started feeling unwell, he suspected he had contracted Tuberculosis. He visited MSF’s clinic in Moreh, on the Indo-Myanmar border, where he was diagnosed with HIV. Lupho had used drugs in the past to gain social acceptance in an area where tribal tensions had fostered a lack of trust amongst people. … Read more